Indian markets are down, presenting a buying opportunity for long-term investors. Vikas Khemani of Carnelian Asset Management sees potential in banking, aviation, and pharma sectors. He believes geopolitical fears are fading, which could lead to a market bounce. Investors with a two to three year outlook can find good prices on desired stocks.Read More
Market expert Vijay Kedia backed Mohandas Pai’s call for open-market buybacks to stabilise equities, saying retail investors quietly held markets together amid relentless FII selling. With benchmarks sliding nearly 10% in a month, sentiment improved slightly after Donald Trump signalled progress in U.S.–Iran talks.Read More
Market expert Sameer Dalal views HDFC Bank as a ‘screaming buy’ despite current market jitters and governance concerns. He believes the bank’s current valuation offers a significant discount, and anticipates growth acceleration as India’s economy recovers, making it a long-term opportunity.Read More
Urban Company shares rose around 3% after Motilal Oswal initiated coverage with a Neutral rating, citing balanced risk-reward at current valuations. While strong growth prospects and market leadership support the outlook, concerns around valuation, competition and gradual consumer adoption limit upside potential, with a target price of Rs 125.Read More
Manipal Health Enterprises, backed by Temasek, is launching its IPO, aiming to raise approximately 80 billion rupees. This move signals confidence in India’s growing need for specialized healthcare services. The hospital chain’s draft prospectus reveals plans for a fresh share issuance and a sale by existing investors, positioning it for expansion in the burgeoning medical sector.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
